Study Links Sleep Quality to Lower Cancer Risk via 303-Protein Signature

Researchers analyzing data from nearly half a million people in the UK Biobank have found a measurable link between how well someone sleeps and their risk of developing cancer. The work, presented at Digestive Disease Week 2026, goes beyond the familiar advice to get eight hours a night—it looks at sleep as a multidimensional thing: how long you sleep, whether you're a morning or evening person, whether you struggle with insomnia, whether you snore, and how tired you feel during the day. When researchers scored 472,105 participants on these five dimensions, those with healthy sleep patterns showed a 36 percent lower risk of liver cancer and a 14 percent lower risk of lung cancer compared to those with poor sleep.

But the study's most striking finding emerged from a deeper dive into biology. The team examined blood samples from nearly 53,000 of those participants and identified 303 proteins that clustered together in a pattern the researchers call a "sleep proteomic score." People whose blood showed the highest levels of this protein signature had dramatically lower cancer risks: 71 percent lower for liver cancer, 54 percent lower for stomach cancer, 53 percent lower for pancreatic cancer, 54 percent lower for gallbladder cancer, 35 percent lower for esophageal cancer, and 28 percent lower for colorectal cancer. The gap between the cohort-level findings and the protein-level findings suggests that something measurable in the blood—something tied to sleep quality—may be doing protective work at the cellular level.

The researchers built their sleep health score by categorizing participants into three groups: those with healthy sleep (a score of 4 or higher), those with intermediate sleep (2 to 3), and those with poor sleep (1 or lower). This approach deliberately moves away from the common focus on duration alone. The National Cancer Institute has noted that sleep health encompasses duration, efficiency, quality, timing, and regularity, and that poor sleep may increase cancer risk by disrupting immune function, stress response, inflammation regulation, and DNA repair—the cellular machinery that normally catches and fixes mutations before they become dangerous.

The biological plausibility is there. Earlier research has shown that sleep deprivation affects the immune system in ways similar to physical stress, with white blood cell counts rising during periods of wakefulness. Adequate sleep is considered one of the lifestyle habits linked to longer life and better overall health. A large international study published in Nature Medicine found that nearly 40 percent of global cancer diagnoses are tied to modifiable risk factors—things people can actually change—which positions sleep as a potentially significant prevention target.

The researchers were careful to note what their work does not show. This is an observational study, meaning they observed associations between sleep quality and cancer risk, but they cannot prove that improving sleep will lower cancer risk. The 303-protein signature offers clues about potential biological pathways, but those pathways need to be confirmed in further research. The team called for additional studies to validate the findings and to test whether interventions that improve sleep across multiple dimensions can actually reduce cancer incidence. What the study does suggest is that sleep quality—measured not just by hours but by the full picture of how someone sleeps—may be one of the more accessible levers people have for supporting their long-term health.